Urenco Finance N.V. Publication of Final Terms (5279O)
10 Juin 2022 - 4:35PM
UK Regulatory
TIDM44ZP
RNS Number : 5279O
Urenco Finance N.V.
10 June 2022
URENCO FINANCE N.V.
[10] June 2022
Publication of Final Terms
The following Final Terms are available for viewing:
Final Terms dated 9 June 2022 in respect of an issue of
EUR500,000,000 3.250 per cent. Notes due 2032 (the Notes).
The Notes are issued under the EUR3,000,000,000 Euro Medium Term
Note Programme established by Urenco Finance N.V. as Issuer and
unconditionally and irrevocably guaranteed on a joint and several
basis by Urenco Limited, Urenco UK Limited, Urenco Nederland B.V.,
Urenco Deutschland GmbH and Louisiana Energy Services, LLC.
The Final Terms in respect of the Notes must be read in
conjunction with the Base Prospectus dated 27 May 2022 (the Base
Prospectus). Full information on Urenco Finance N.V., and in
respect of the offer of the Notes, is only available on the basis
of the combination of the Base Prospectus and the Final Terms in
respect of the Notes.
To view the Final Terms in respect of the Notes, please paste
the URL below into the address bar of your browser.
https://www.urenco.com/cdn/uploads/supporting-files/Project_Chester_-_Final_Terms_(signed)_-_Conformed_Copy(259691706.1)_.pdf
A copy of the Final Terms will be submitted to the National
Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Urenco Limited
Urenco Court
Sefton Park
Bells Hill
Stoke Poges
Bucks SL2 4JS
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Final Terms in
respect of the Notes (when read together with the information in
the Base Prospectus) may be addressed to and/or targeted at persons
who are residents of particular countries (specified in the Base
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Final Terms and Base Prospectus is not
addressed. Prior to relying on the information contained in the
Final Terms and the Base Prospectus you must ascertain whether or
not you are part of the intended addressees of the information
contained therein.
In particular, the Base Prospectus and the Final Terms in
respect of the Notes do not constitute an offer of securities for
sale in the United States. The Notes have not been, and will not
be, registered under the U.S. Securities Act of 1933, as amended,
(the Securities Act) or under any relevant securities laws of any
state of the United States of America and may not be offered or
sold to U.S. persons or to persons within the United States of
America except in certain transactions exempt from, or not subject
to, the registration requirements of the Securities Act.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PFTFLFVSRFIILIF
(END) Dow Jones Newswires
June 10, 2022 10:35 ET (14:35 GMT)
Urenco 24 (LSE:44ZP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Urenco 24 (LSE:44ZP)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024